<DOC>
	<DOCNO>NCT00496080</DOCNO>
	<brief_summary>The objective study evaluate safety effectiveness Doppler guide uterine artery occlusion ( D-UAO ) reduction fibroid associate bleeding .</brief_summary>
	<brief_title>Doppler-Guided Uterine Artery Occlusion ( DUAO ) Device Fibroid Related Bleeding</brief_title>
	<detailed_description>The GYNECARE GYNOCCLUDE D-UAO Instruments single-use disposable instrument consist GYNECARE GYNOCCLUDE Uterine Stabilizer , GYNECARE GYNOCCLUDEM Introducer Sheath , GYNECARE GYNOCCLUDE Doppler Clamp , GYNECARE GYNOCCLUDE Coupler .</detailed_description>
	<mesh_term>Leiomyoma</mesh_term>
	<mesh_term>Myofibroma</mesh_term>
	<mesh_term>Menorrhagia</mesh_term>
	<criteria>25 50 year age ; PBLAC score 150 great ; Completed childbearing ; Normal Pap smear within 12 month ; Cervix suitable tenaculum placement determine pelvic exam ; At least one uterine fibroid 3 cm diameter great prevail pathology ( e.g. , opposed adenomyosis ) fibroid determine ultrasound ; Willing maintain use nonuse hormonal contraception 3 month prestudy throughout 12month followup period ; Willing maintain use nonuse antifibrinolytic agent 3 month prestudy throughout 12month followup period ; Able tolerate require prolonged supine position treatment ( approximately 6 hour ) ; Willing able provide inform consent follow studyrelated requirement ; Pregnancy ( confirm immediately prior procedure ) Fibroid diameter great 8.0 cm determine transvaginal ultrasound ; [ 2 dimension measure , total dimension great 16 cm ; 3 dimension ( length , height , width ) measure , total dimension great 24 cm ] ; Presence pedunculated fibroid determine ultrasound ; hysteroscopy , saline infused sonography ; Hydronephrosis determine radiologist interpretation renal ultrasound preprocedurally ; Menopausal ; Clinical history thromboembolic disease ; Blood urine nitrogen ( BUN ) great 20 mg/dL and/or serum creatinine great 1.2 mg/dL unresolved change diet hydration ; Â· One low uterine segment fibroid determine pelvic exam ; History gynecologic malignancy , atypical endometrial hyperplasia , pelvic inflammatory disease ; Abnormal endometrial biopsy within last 6 month prior procedure ; Pelvic mass outside uterus suggest disease process ; Any current acute chronic systemic infection localize pelvic infection , include unresolved urinary tract infection ; Using GnRH agonist mifepristone within 6months prior start study ; An intrauterine device ( IUD ) place ; Using anticoagulation therapy ( except OTC treatment ( e.g . aspirin ) ) , underlie bleed disorder ; Unsuitable MRI examination , within study subgroup undergo MRI evaluation ( e.g . severe claustrophobia , nonMRIcompatible implant metalloid device ) ; Prior endometrial ablation , uterine artery embolization , uterine artery ligation ; Poor procedural candidate due medical condition determine investigator ( e.g . anesthesia class , renal insufficiency , heart disease ) ; Grade 1 3D Color Doppler flow observe cystoscopy ureter flow assessment applicable .</criteria>
	<gender>Female</gender>
	<minimum_age>25 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>September 2012</verification_date>
	<keyword>Menorrhagia associate Uterine Fibroids</keyword>
</DOC>